Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension-Reference-Cited by-同舟云学术

Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension

Published:2019-04 Issue:7 Volume:199 Page:891-902
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Nikolic Ivana¹^ORCID,Yung Lai-Ming¹^ORCID,Yang Peiran¹^ORCID,Malhotra Rajeev²^ORCID,Paskin-Flerlage Samuel D.¹,Dinter Teresa¹^ORCID,Bocobo Geoffrey A.¹,Tumelty Kathleen E.³,Faugno Anthony J.⁴,Troncone Luca¹,McNeil Megan E.¹,Huang Xiuli⁵,Coser Kathryn R.³,Lai Carol S. C.¹,Upton Paul D.⁶^ORCID,Goumans Marie Jose⁷^ORCID,Zamanian Roham T.⁸^ORCID,Elliott C. Gregory⁹,Lee Arthur⁵,Zheng Wei⁵,Berasi Stephen P.³,Huard Christine³,Morrell Nicholas W.⁶^ORCID,Chung Raymond T.¹⁰,Channick Richard W.¹¹,Roberts Kari E.⁴,Yu Paul B.¹^ORCID

Affiliation:

1. Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

2. Division of Cardiology

3. Pfizer Centers for Therapeutic Innovation, Cambridge, Massachusetts

4. Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Tufts Medical Center, Boston, Massachusetts

5. Therapy for Rare and Neglected Diseases Program, National Center for Advancing Translational Sciences, Rockville, Maryland

6. Division of Respiratory Medicine, Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke’s and Papworth Hospitals, Cambridge, United Kingdom

7. Department of Molecular Cell Biology and Cancer Genomics Centre Netherlands, Leiden University Medical Centre, Leiden, the Netherlands

8. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University Medical Center, Stanford, California; and

9. Department of Medicine, Intermountain Medical Center and University of Utah, Salt Lake City, Utah

10. Gastrointestinal Unit and Liver Center, and

11. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.201807-1236OC

Reference30 articles.

1. Definitions and Diagnosis of Pulmonary Hypertension

2. Updated Clinical Classification of Pulmonary Hypertension

3. Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension

4. Familial Primary Pulmonary Hypertension (Gene PPH1) Is Caused by Mutations in the Bone Morphogenetic Protein Receptor–II Gene

5. Genetics and Genomics of Pulmonary Arterial Hypertension

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating biomarkers in pulmonary arterial hypertension: State-of-the-art review and future directions;JHLT Open;2024-11

2. Hepatopulmonary Syndrome, Another Face of Dysregulated BMP9 Signaling;American Journal of Respiratory and Critical Care Medicine;2024-09-01

3. Disrupted BMP-9 Signaling Impairs Pulmonary Vascular Integrity in Hepatopulmonary Syndrome;American Journal of Respiratory and Critical Care Medicine;2024-09-01

4. Pathology and pathobiology of pulmonary hypertension: current insights and future directions;European Respiratory Journal;2024-08-29

5. Unveiling the Impact of BMP9 in Liver Diseases: Insights into Pathogenesis and Therapeutic Potential;Biomolecules;2024-08-15